Source:http://linkedlifedata.com/resource/pubmed/id/17325901
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2007-2-27
|
pubmed:abstractText |
Cyclooxygenase 2 (Cox-2) is a key enzyme in prostaglandin synthesis and it has an important role in the pathogenesis of various malignancies. Cox-2 has been studied in solid tumors; however, studies about the role of Cox-2 in non-Hodgkin's lymphomas (NHL) are limited. The aim of this study is to determine the importance of Cox-2 expression in lymphomas. To this end, Cox-2 expression was determined in 177 cases with NHL. In histological terms, 60 cases (33%) had low grade and 117 (67%) had aggressive lymphoma. Ninety-nine cases were found to be positive for Cox-2 (56%); Cox-2 score was between 50 and 100, 101 and 200 and over 200 in 38, 46 and 15 cases, respectively. There was an important association between aggressive histology and Cox-2 expression: Cox-2 was negative in about half of the cases with indolent morphology, while two thirds of the Cox-2 positive cases had aggressive histology (p = 0.036). There was no significant association between Cox-2 expression and clinical-laboratory parameters. Although the overall survival times were longer in cases with lower or no Cox-2 expression as compared with higher Cox-2 expression, the difference was not significant. In conclusion Cox-2 expression is seen about 60% of the cases with NHL and is associated with aggressive morphology.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1042-8194
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
48
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
389-95
|
pubmed:dateRevised |
2009-11-3
|
pubmed:meshHeading |
pubmed-meshheading:17325901-Adolescent,
pubmed-meshheading:17325901-Adult,
pubmed-meshheading:17325901-Aged,
pubmed-meshheading:17325901-Aged, 80 and over,
pubmed-meshheading:17325901-Cyclooxygenase 2,
pubmed-meshheading:17325901-Female,
pubmed-meshheading:17325901-Humans,
pubmed-meshheading:17325901-Immunoenzyme Techniques,
pubmed-meshheading:17325901-Lymphoma, Large B-Cell, Diffuse,
pubmed-meshheading:17325901-Lymphoma, Mantle-Cell,
pubmed-meshheading:17325901-Lymphoma, Non-Hodgkin,
pubmed-meshheading:17325901-Lymphoma, T-Cell, Peripheral,
pubmed-meshheading:17325901-Male,
pubmed-meshheading:17325901-Membrane Proteins,
pubmed-meshheading:17325901-Middle Aged,
pubmed-meshheading:17325901-Neoplasm Staging,
pubmed-meshheading:17325901-Prognosis,
pubmed-meshheading:17325901-Survival Rate
|
pubmed:year |
2007
|
pubmed:articleTitle |
Cyclooxygenase-2 expression in non-Hodgkin's lymphomas.
|
pubmed:affiliation |
Department of Oncology, Faculty of Medicine, Cukurova University, Adana, Turkey. sepay@cu.edu.tr
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|